Profil
Ivan M.
Borrello is the founder of WindMIL Therapeutics, Inc. He is currently the Director at Cellular Therapeutics Ltd. Prior to this, he served as an Independent Director at Gamida Cell Ltd. from 2022 to 2024.
Dr. Borrello completed his undergraduate degree at The Catholic University of America and obtained his doctorate from the Medical College of Virginia.
Postes actifs de Ivan Borrello
| Sociétés | Poste | Début |
|---|---|---|
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Directeur/Membre du Conseil | - |
Anciens postes connus de Ivan Borrello
| Sociétés | Poste | Fin |
|---|---|---|
| GAMIDA CELL LTD. | Directeur/Membre du Conseil | 24/05/2024 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Fondateur | - |
Formation de Ivan Borrello
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Catholic University of America
The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd. BiotechnologyHealth Technology Manufactures cell therapy products | Health Technology |
















